BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021

Mar 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-03-15

Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-15	Common Stock	A	10720	—	Acquired	72001	Direct
2021-03-15	Common Stock	F	5273	$78.39	Disposed	66728	Direct
2021-03-16	Common Stock	F	1287	$77.21	Disposed	65441	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to buy Common Stock)	$78.39	A	26400	Acquired	2031-03-14	Common Stock (26400)	Direct

Footnotes

F1: Restricted stock units granted on March 15, 2021. Price not applicable.

F2: Option grant vests 12/48th on March 15, 2022 and 1/48th on the 15th day of each month thereafter.